Endovascular embolization of the swine rete mirabile with Eudragit-E 100 polymer

American Journal of Neuroradiology

Volumn 28, Issue 6, 2007, Pages 1191-1196

  Arakawa, Hideki ^a,c,d   Murayama, Y ^c   Davis, C R ^b   Howard, D L ^a   Baumgardner, W L ^a   Marks, M P ^a,b   Do, H M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JIKEI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COPOLYMER; ENBUCRILATE; EUDRAGIT; EUDRAGIT E 100; IOPAMIDOL; METHACRYLIC ACID DERIVATIVE; POLY(METHYL METHACRYLATE); POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS MALFORMATION; ARTERY CALCIFICATION; ARTICLE; BRAIN ANGIOGRAPHY; ENDOTHELIUM INJURY; ENDOVASCULAR EMBOLIZATION; EXTRAVASATION; FIBROSIS; FOLLOW UP; HISTOPATHOLOGY; INFLAMMATION; NONHUMAN; RECANALIZATION; SWINE; THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

ACRYLATES; ANIMALS; CRANIAL SINUSES; EMBOLIZATION, THERAPEUTIC; POLYMERS; SWINE; TREATMENT OUTCOME;

EID: 34250817388     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A0536     Document Type: Article

References (22)

1. Becker TA, Kipke DR, Preul MC, et al. In vivo assessment of calcium alginate gel for endovascular embolization of a cerebral arteriovenous malformation model using the swine rete mirabile. Neurosurgery 2002;51:453-59
2. Hamada J, Kai Y, Morioka M, et al. A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study. J Neurosurg 2002;97:889-95
3. Klisch J, Yin L, Requejo F, et al. Liquid 2-poly-hydroxyethyl- methacrylate embolization of experimental arteriovenous malformations: feasibility study. AJNR Am J Neuroradiol 2002;23:422-29
4. Taki W, Yonekawa Y, Iwata H, et al. A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol 1990;11:163-68
5. Yamashita K, Taki W, Iwata H, et al. A cationic polymer, Eudragit-E, as a new liquid embolic material for arteriovenous malformations. Neuroradiology 1996;38(suppl 1):S151-56
6. Kinugasa K, Mandai S, Terai Y, et al. Direct thrombosis of aneurysms with cellulose acetate polymer. Part II. Preliminary clinical experience. J Neurosurg 1992;77:501-07
7. Mandai S, Kinugasa K, Ohmoto T. Direct thrombosis of aneurysms with cellulose acetate polymer. Part I. Results of thrombosis in experimental aneurysms. J Neurosurg 1992;77:497-500
8. Kazekawa K, Iwata H, Shimozuru T, et al. Nontoxic embolic liquids for treatment of arteriovenous malformations. J Biomed Mater Res 1997;38:79-86
9. Oowaki H, Matsuda S, Sakai N, et al. Non-adhesive cyanoacrylate as an embolic material for endovascular neurosurgery. Biomaterials 2000;21:1039-46
10. Murayama Y, Vinuela F, Ulhoa A, et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 1998;43:1164-75
11. Sadato A, Numaguchi Y, Taki W, et al. Nonadhesive liquid embolic agent: role of its components in histologic changes in embolized arteries. Acad Radiol 1998;5:198-206
12. Shi Z, Huang Z, Zhang Y, et al. Experimental study of Eudragit mixture as a new nonadhesive liquid embolic material. Chin Med J (Engl) 2002;115:555-58
13. Brothers MF, Kaufmann JC, Fox AJ, et al. n-butyl 2-cyanoacrylate- substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. AJNR Am J Neuroradiol 1989;10:777-86
14. Lasjaunias P, Berenstein A. Technical aspects of surgical neuroangiography. In: Lasjaunias P, Berenstein A, eds. Surgical Neuro-Angiography (2): Endovascular Treatment of Craniofacial Lesions. Berlin, Germany: Springer-Verlag; 1989:1-56
15. Sampei K, Hashimoto N, Kazekawa K, et al. Histological changes in brain tissue and vasculature after intracarotid infusion of organic solvents in rats. Neuroradiology 1996;38:291-94
16. Fournier D, Terbrugge K, Rodesch G, et al. Revascularization of brain arteriovenous malformations after embolization with bucrylate. Neuroradiology 1990;32:497-501
17. Vinters HV, Lundie MJ, Kaufmann JC. Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate. N Engl J Med 1986;314:477-83
18. n-BCA Trial Investigators. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 2002;23:748-55
19. Gruber A, Mazal PR, Bavinzski G, et al. Repermeation of partially embolized cerebral arteriovenous malformations: a clinical, radiologic, and histologic study. AJNR Am J Neuroradiol 1996;17:1323-31
20. Tan Y, Huang L. Overcoming the inflammatory toxicity of cationic gene vectors. J Drug Target 2002;10:153-60
21. Turunen MP, Hiltunen MO, Ruponen M, et al. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther 1999;6:6-11
22. Jahan R, Murayama Y, Gobin YP, et al. Embolization of arteriovenous malformations with Onyx: clinicopathologjcal experience in 23 patients. Neurosurgery 2001;48:984-97